Navigation Links
Good News For Those Of You Suffering From Rheumatoid Arthritis

Combination therapy with the new biologic drug adalimumab and methotrexate has been found to be about five times more effective for people with long-standing rheumatoid arthritis when compared to the usual management // with methotrexate alone. It has been found to decrease pain and swelling in patients who fail to respond to standard treatment.

At the end of the 6-month trial, 43 percent of all subjects on adalimumab plus methotrexate had achieved a 50-percent improvement in symptoms, compared with 9 percent of all subjects receiving placebo plus methotrexate. In addition, adalimumab injections slowed progression of joint damage as revealed by joint X-rays.

Rheumatoid arthritis is an autoimmune disease, which develops when certain cells of the immune system malfunction and attack healthy joints. The cause of rheumatoid arthritis is unknown. The primary focus of the inflammation is in the synovium, the lining tissue of the joint. Inflammatory chemicals released by the immune cells cause swelling and damage to cartilage and bone.

Adalimumab works by preventing a protein called tumor necrosis factor (TNF) from signaling the release of joint-damaging substances. Adalimumab is approved for the treatment of moderate to severe rheumatoid arthritis in adults who do not respond to other treatments.

Addressing future research priorities, long-term efficacy and safety studies are needed before this therapy can be put into clinical practice.


Page: 1

Related medicine news :

1. Identifying Those At Risk For Diabetes
2. Identifying Those At Risk For Diabetes
3. Hope For Those With Pancreatic Cancer
4. Good News For Those Suffering From Excessive Sweating
5. Cell Implants May Help Those Who Suffer From Parkinsons
6. Firms Told To Employ Those With Aspergers Syndrome
7. Statins Prescribed To Those Who Are At a Risk Of Developing A Heart Disease
8. Adventure Enthusiasts, Risk Takers and Those Living on the Edge, Good News Coming Your Way
9. Number of Allergic Anaphylaxis Episodes Are Far More Than Those Recorded
10. Korea: No Discrimination against Those with AIDS/HIV in the Workplace
11. Free Herceptin Treatment for Those Who Live Over the Welsh Border
Post Your Comments:

(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
(Date:6/24/2016)... New York, NY (PRWEB) , ... June 24, ... ... lifestyle publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as ... believes that “the most beautiful women in the world, and the most handsome ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC ... by obtaining investment capital for emerging technology companies. SCP has delivered investment ... resulted in more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... ... Venture Construction Group (VCG) sponsors Luke’s Wings 5th ... Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event raised ... have been wounded in battle and their families. Venture Construction Group is a 2016 ...
(Date:6/24/2016)... Gilbert, Arizona (PRWEB) , ... June 24, 2016 ... ... Gilbert-based practice, is supporting the upcoming 2016 Miss Arizona pageant as its official ... primarily serves Scottsdale, Tempe, Mesa, and Chandler, Arizona. , Dr. Olson says ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
Breaking Medicine Technology: